Changli Wang Selected Research

icotinib

7/2016	[China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2016 version)].
10/2015	China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version).
10/2015	China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version).
7/2015	[China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2015 version)].
9/2014	[Cetuximab in combination with icotinib overcomes the acquired resistance caused by EGFR T790M mutation in non-small cell lung cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Changli Wang Research Topics

Disease

58	Neoplasms (Cancer) 03/2024 - 10/2004
48	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 07/2006
28	Lung Neoplasms (Lung Cancer) 08/2023 - 10/2004
16	Adenocarcinoma of Lung 01/2022 - 03/2009
15	Neoplasm Metastasis (Metastasis) 01/2023 - 03/2008
8	Inflammation (Inflammations) 01/2024 - 12/2013
6	Carcinogenesis 10/2022 - 07/2006
5	Sepsis (Septicemia) 01/2024 - 04/2017
4	Disease Progression 01/2023 - 08/2011
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 10/2020
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2015
4	Adenocarcinoma 03/2021 - 03/2009
3	Cardiotoxicity 11/2023 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 03/2008
3	Myocardial Infarction 11/2019 - 09/2018
3	Acute Lung Injury 03/2019 - 06/2018
2	Neuroblastoma 03/2024 - 01/2016
2	Body Weight (Weight, Body) 01/2024 - 01/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 09/2023
2	Ulcerative Colitis 11/2023 - 01/2021
2	Carcinoma (Carcinomatosis) 09/2023 - 11/2013
2	Stomach Neoplasms (Stomach Cancer) 09/2023 - 01/2019
2	Colitis 12/2022 - 01/2021
2	Residual Neoplasm 02/2022 - 01/2022
2	COVID-19 01/2022 - 11/2020
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2019
2	Endotoxemia 01/2019 - 01/2018
2	Exanthema (Rash) 11/2018 - 08/2011
2	Pulmonary Edema 07/2018 - 06/2018
1	Insulin Resistance 01/2024

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2012
10	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2012
9	CytokinesIBA 01/2022 - 01/2009
8	MicroRNAs (MicroRNA)IBA 03/2022 - 11/2012
8	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2011
7	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 06/2018
6	CateninsIBA 09/2023 - 11/2012
5	NivolumabIBA 03/2023 - 01/2021
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2022 - 08/2011
5	Cadherins (E-Cadherin)IBA 12/2016 - 01/2012
5	icotinibIBA 07/2016 - 09/2014
4	Volatile Oils (Essential Oils)IBA 12/2023 - 01/2021
4	ErbB Receptors (EGF Receptor)IBA 12/2022 - 03/2011
4	Messenger RNA (mRNA)IBA 03/2022 - 01/2017
4	VimentinIBA 03/2015 - 01/2012
3	RNA (Ribonucleic Acid)IBA 11/2023 - 09/2018
3	AntigensIBA 09/2023 - 01/2019
3	Docetaxel (Taxotere)FDA Link 08/2023 - 10/2013
3	OsteopontinIBA 10/2021 - 03/2008
3	ChemokinesIBA 10/2021 - 02/2012
3	LigandsIBA 10/2021 - 01/2019
3	Carboplatin (JM8)FDA LinkGeneric 08/2021 - 08/2011
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2018
3	Therapeutic UsesIBA 01/2021 - 01/2019
3	LipopolysaccharidesIBA 03/2019 - 01/2018
2	Galectin 3 (LGALS3)IBA 03/2024 - 09/2023
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 04/2017
2	PlatinumIBA 01/2024 - 01/2021
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2023 - 12/2022
2	Dextrans (Dextran)FDA Link 11/2023 - 12/2022
2	Sirtuin 1IBA 08/2023 - 10/2016
2	Vinorelbine (Navelbine)FDA LinkGeneric 12/2022 - 11/2018
2	Epidermal Growth Factor (EGF)IBA 12/2022 - 04/2017
2	MucinsIBA 11/2022 - 02/2014
2	Circulating Tumor DNAIBA 02/2022 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	EnzymesIBA 01/2022 - 01/2021
2	Long Noncoding RNAIBA 12/2021 - 09/2021
2	ceritinibIBA 01/2021 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2019 - 11/2012
2	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2019 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2019 - 12/2016
2	Acetates (Acetic Acid Esters)FDA Link 03/2019 - 01/2019
2	Alkaline PhosphataseIBA 01/2019 - 01/2018
2	AlbuminsIBA 01/2019 - 01/2019
2	Gefitinib (Iressa)FDA Link 06/2018 - 03/2011
2	Alanine Transaminase (SGPT)IBA 01/2018 - 08/2011
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 07/2006
2	Cetuximab (Erbitux)FDA Link 09/2014 - 12/2013
1	Conditioned Culture MediaIBA 03/2024
1	Insulin (Novolin)FDA Link 01/2024
1	Blood Glucose (Blood Sugar)IBA 01/2024
1	Streptozocin (Streptozotocin)FDA Link 01/2024
1	FlavonesIBA 01/2024
1	toripalimabIBA 01/2024
1	CannabidiolIBA 01/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024

Therapy/Procedure

20	Therapeutics 09/2023 - 01/2009
16	Drug Therapy (Chemotherapy) 01/2024 - 01/2009
9	Immunotherapy 01/2024 - 11/2012
8	Radiotherapy 08/2023 - 10/2009
8	Neoadjuvant Therapy 10/2022 - 12/2013
5	Adjuvant Chemotherapy 12/2022 - 06/2008
3	Ligation 11/2022 - 01/2018
2	Punctures 11/2022 - 01/2018
2	Lymph Node Excision (Lymph Node Dissection) 07/2022 - 10/2004
2	Aftercare (After-Treatment) 01/2022 - 12/2017
2	Pneumonectomy (Lung Volume Reduction) 02/2006 - 10/2004